Suven Pharmaceuticals Ltd., incorporated in the year 2018, is a Small Cap company (having a market cap of Rs 12771.52 Crore) operating in Pharmaceuticals sector.
Suven Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Duty Drawback and Export Incentives for the year ending 31-Mar-2021.
Financials
For the quarter ended 30-09-2021, the company reported a Consolidated Total Income of Rs 306.03 Crore, up 13.52 % from last quarter Total Income of Rs 269.58 Crore and up 28.72 % from last year same quarter Total Income of Rs 237.74 Crore. Company reported net profit after tax of Rs 79.52 Crore in latest quarter.
Investment Rationale
Formulations have registered healthy growth due to increased commercial basket & have a pipeline of six ANDAs in FY22, enhancing growth levers
Promoter/FII Holdings
Promoters held 60.0 per cent stake in the company as of 30-Sep-2021, while FIIs owned 8.03 per cent, DIIs 5.82 per cent.
(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.
